Product
Standard treatment
Name
Standard treatment
4 clinical trials
6 indications
Indication
TuberculosisIndication
Plantar FasciitisIndication
Advanced Solid TumorIndication
Urinary Tract InfectionsIndication
BacteremiaIndication
Antibiotic Resistant InfectionClinical trial
A Multi-center, Randomized, Positive-controlled Phase 2 Clinical Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of WX-081 in Participants With Drug-naive&Susceptible or Drug-Resistant Pulmonary TuberculosisStatus: Completed, Estimated PCD: 2022-04-13
Clinical trial
Efficacy of an Early Intervention Programme Using Therapeutic Exercise in Patients With Plantar FasciopathyStatus: Not yet recruiting, Estimated PCD: 2024-05-10
Clinical trial
An Open-label, Dose Escalation and Dose Expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of STI-7349 in Subjects With Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in Febrile UTIs Caused by ESBL-producing Enterobacterales (PACUTI)Status: Recruiting, Estimated PCD: 2027-09-01